Cyril Amarchand Mangaldas, JSA act on Suraksha Diagnostic IPO

Suraksha Diagnostic Limited has made an initial public offering aggregating to Rs. 846 Crore, comprising of an offer for sale by OrbiMed Asia II Mauritius Limited, Dr. Somnath Chatterjee, Ritu Mittal, Satish Kumar Verma, Munna Lal Kejriwal and Santosh Kumar Kejriwal.

Cyril Amarchand Mangaldas advised Suraksha Diagnostics on this IPO.

The transaction team was led by Priyadarshini Rao (Partner).

JSA advised the Bankers ICICI Securities Limited, Nuvama Wealth Management Limited and SBI Capital Markets Limited on this IPO.

The transaction team consisted of Arka Mookerjee (Lead Partner), Pracheta Bhattacharya (Partner), Sourav Modi (Senior Associate), Dhvanit Kothari (Associate), Jeebitesh Bhattacharya (Associate), Ankesh Kumar (Associate) and Anoop Mukundan (Junior Associate).

Suraksha Diagnostic Limited offers one-stop integrated solutions for pathology and radiology testing and medical consultation services through their operational network consisting of a central reference laboratory, satellite laboratories, diagnostic centres, and sample collection centres.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.